Wakely Wire

New Insights

Whitepapers, briefs, press releases and more

Summary of CY2026 Final Rate Announcement & CY2026 Final Part D Redesign Instructions

The Centers for Medicare & Medicaid Services (CMS) recently released the Announcement of Calendar Year (CY) 2026 Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies, which finalizes important changes in plan payments, risk adjustment and other financial and regulatory requirements for 2026. In tandem, CMS released the ‘Final CY 2026 ... Read more

Continue reading

Final 2026 HHS HCC Risk Adjustment Model Impact Estimates

In this paper, we analyze the impact of risk adjustment model changes from the final 2026 HHS HCC risk adjustment model based on 2024 data collected through the WNRAR project. We scored data with the final 2024, final 2025, and final 2026 HHS HCC risk adjustment models and summarized the impact to risk scores and ... Read more

Continue reading

Week in Washington 04/17/25

Prescription Drug Tariffs A notice was published in the Federal Register that effectively is a precursor to the Administration applying tariffs on imported drugs. The review includes not just the drugs but also components such as active pharmaceutical ingredients and key starting material (i.e., potential for a very broad tariff).  Feedback is due in 21 ... Read more

Continue reading

Events & More

PACE - Part D Funding

This webinar will be focused on changes to Medicare Part D, highlighting where responsibility has shifted from CMS to the Medicare plans and PACE organizations in the catastrophic phase of coverage.

Read more

Newsworthy Findings

HHS Layoffs May be Illegal, Legal Experts Say

The federal health department sidestepped normal reduction-in-force procedures this month as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint.

Read full article
Editor's Note
There is a chance that layoffs at HHS may be unlawful. Potential issues include the closure of entire offices, including some mandated by law; discrepancies in how the HHS determined which employees would be let go; incorrect information on termination letters; and a lack of transparency with department heads and HHS unions. Several legal experts agree that some of those reasons could be grounds for a suit.

Trump Signals Plan to Address ‘Pill Penalty’ of Drug Pricing Law

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the industry, and could augur a new push for Medicare site neutrality.

Read full article
Editor's Note
President Trump signals plans to address the so-called “pill penalty” in the Inflation Reduction Act. The move could delay Medicare price negotiations for small molecule drugs, aligning them more closely with biologics and marking a notable shift in the administration’s approach to pharmaceutical pricing.

Medicare Proposes 2.4% Pay Hike for Inpatient Hospitals Next Year

The rate increase is the lowest since 2019. The American Hospital Association slammed it as inadequate.

Read full article
Editor's Note
The modest payment increase comes as many hospitals continue to grapple with rising costs and inflation. This could accelerate shifts toward lower-cost outpatient care and lead to service reductions. A fuller picture of the rule’s financial impact will emerge as publicly traded hospitals report first-quarter earnings later this month.

US Launches Probe That Could Set Stage for Pharma Tariffs

The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.

Read full article
Editor's Note
While the tariff model aims to boost domestic pharmaceutical manufacturing, it could carry significant costs for drugmakers, potentially limiting investment in research and development. The Commerce Department has also raised concerns about whether U.S. production capacity can meet demand.

CMS Rejects Humana’s Medicare Advantage Star Ratings Appeal

The CMS has denied Humana’s internal appeal to improve the insurer’s Medicare Advantage bonus ratings, Humana disclosed in a filing on Tuesday in its ongoing litigation against the government for allegedly arbitrarily calculating the scores.

Read full article
Editor's Note
The decision will be finalized on April 28th and is subject to review by the new CMS Administrator, Dr. Mehmet Oz.

Bonus Article

Just for Fun

Math Joke

If seven people meet each other and each shake hands only once with each of the others, how many handshakes happened?

Prior Week

Q: Why was the equal sign so humble?
A: Because it knew it wasn’t less than or greater than anyone else.

Sign up for the
Wakely Wire,

our industry newsletter.